Haemophilus influenzae B immunisation.
D001426:Bacterial Proteins / Q000009:adverse effects / Q000627:therapeutic use*; D001428:Bacterial Vaccines / Q000009:adverse effects / Q000627:therapeutic use*; D002675:Child, Preschool; D006192:Haemophilus Infections / Q000517:prevention & control*; D018073:Haemophilus Vaccines; D006193:Haemophilus influenzae; D006801:Humans; D007114:Immunization; D007223:Infant; D007231:Infant, Newborn; D013745:Tetanus Toxoid / Q000009:adverse effects / Q000627:therapeutic use*
D001426:Bacterial Proteins; D001428:Bacterial Vaccines; D018073:Haemophilus Vaccines; C055753:Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate; D013745:Tetanus Toxoid; C061963:HibTITER protein, Haemophilus influenzae